References
- SzebeniJMuggiaFMAlvingCRComplement activation by cremophor EL as a possible contributor to hypersensitivity to paclitaxel: An in vitro studyJ Natl Cancer Inst19989043003069486816
- MichaudLBValeroVHortobagyiGRisks and benefits of taxanes in breast and ovarian cancerDrug Saf200023540142811085347
- DosioFBrusaPCrosassoPArpiccoSCattelLPreparation, characterization and properties in vitro and in vivo of a paclitaxel-albumin conjugateJ Control Release1997473293304
- SkwarczynskiMHayashiYKisoYPaclitaxel prodrugs: Toward smarter delivery of anticancer agentsJ Med Chem200649257253726917149855
- MarupudiNIHanJELiKWPaclitaxel: A review of adverse toxicities and novel delivery strategiesExpert Opin Drug Saf20076560962117877447
- DesaiNTeieuVYaoZIncreased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxelClin Cancer Res20061241317132416489089
- GradisharWJTjulandinSDavodsonNPhase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancerJ Clin Oncol200523317794780316172456
- HuhKMLeeSCChoYWLeeJJeongJHParkKHydrotropic polymer micelle system for delivery of paclitaxelJ Control Release20051011–35668
- SuhHJeongBRathiRKimSWRegulation of smooth muscle cell proliferation using paclitaxel-loaded poly(ethylene oxide)-poly(lactide/glycolide) nanospheresJ Biomed Mater Res19984223313389773830
- SeowWYXueJMYangYYTargeted and intracellular delivery of paclitaxel using multi-functional polymeric micellsBiomaterials20072891730174017182095
- ZhangYTangLSunLA novel paclitaxel-loaded poly-(ɛ-caprolactone)/Poloxamer 188 blend nanoparticle overcoming multidrug resistance for cancer treatmentActa Biomater2010662045205219969111
- TemmingKMeyerDLZabinskiREvaluation of RGD-targeted albumin carriers for specific delivery of auristatin E to tumor blood vesselsBioconjug Chem20061761385139417105215
- TemmingKMeyerDLZabinskiRImproved efficacy αvβ3-targeted albumin conjugates by conjugation of a novel auristatin derivativeMol Pharm20074568669417683157
- RahimnejadMJahanshahiMNajafpourGDProduction of biological nanoparticles from bovine serum albumin for drug deliveryAfr J Biotechnol200652019181923
- GreenMRManikhasGMOrlovSAfanasyevBMakhsonAMAbraxane®, a novel Cremophor®-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancerAnn Oncol20061781263126816740598
- MieleESpinelliGPMieleETomaoFTomaoSAlbumin-bound formulation of paclitaxel (Abraxane® ABI-007) in the treatment of breast cancerInt J Nanomedicine200949910519516888
- GradisharWJAlbumin-bound paclitaxel: A next-generation taxaneExpert Opin Pharmacother2006781041105316722814
- GrunerBAWeitmanSDThe folate receptor as a potential therapeutic anticancer targetInvest New Drugs199916320521910360600
- LuYLowPSFolate-mediated delivery of macromolecular anticancer therapeutic agentsAdv Drug Deliv Rev200254567569312204598
- SabharanjakSMayorSFolate receptor endocytosis and traffickingAdv Drug Deliv Rev20045681099110915094209
- ZhengYSongSGDarbyMPreparation and characterization of folate-poly(ethylene glycol)-grafted-trimethylchitosan for intracellular transport of protein through folate receptor-mediated endocytosisJ Biotechnol20091451475319770010
- DosioFArpicoSStellaBBrusaPCattelLFolate-mediated targeting of albumin conjugates of paclitaxel obtained through a heterogeneous phase systemInt J Pharm20093821–211712319712735
- LiFQSuHWangJLiuYJPreparation and characterization of sodium ferulate entrapped bovine serum albumin nanoparticles for live targetingInt J Pharm20083491–227428217870261
- WeberCCoesterCKeruterJLangerKDesolvation process and surface characterization of protein nanoparticlesInt J Pharm200019419110210601688
- ZuYZhangYZhaoXZhangQLiuYJiangROptimization of the preparation process of vinblastine sulfate (VBLS)-loaded folate conjugated bovine serum albumin (BSA) nanoparticles for tumor-targeted drug delivery using response surface methodology (RSM)Int J Nanomedicine2009432133320054435
- LeeRLowPDelivery of liposomes into cultured KB cells via folate receptor mediated endocytosisJ Biol Chem19942695319832048106354
- ZhangLHouSMaoSWeiDSongXLuYUptake of folate-conjugated albumin nanoparticles to the SKOV3 cellsInt J Pharm20042871–215516215541922
- MezianiMJSunYPProtein-conjugated nanoparticles from rapid expansion of supercritical fluid solution into aqueous solutionJ Am Chem Soc2003125268015801812823024
- MerodioMArnedoARenedoMJIracheJMGanciclovir-loaded albumin nanoparticles: Characterization and in vitro release propertiesEur J Pharm Sci200112325125911113644
- ChoWYLeeJLeeSCHuhKMParkKHydrotropic agents for study of in vitro paclitaxel release from polymeric micellesJ Control Release200497224925715196752
- HattoriYMaitaniYEnhanced in vitro DNA transfection efficiency by novel folate-linked nanoparicles in human prostate cancer and oral cancerJ Control Release200497117318315147814
- HolmJHansenSIHoier-MadsenMHigh-affinity folate binding in human prostateBiosci Rep1993132991058374062
- HattoriYMaitaniYFolate-linked nanoparticle-mediated suicide gene therapy in human prostate cancer and nasopharyngeal cancer with herpes simplex virus thymidine kinaseCancer Gene Ther2005121079680915891776
- PaalKMullerJHegedusLHigh affinity binding of paclitaxel to human serum albuminEur J Biochem200126872187219111277943
- HaleyBFrenkelENanoparticles for drug delivery in cancer treatmentUrol Oncol2008261576418190833